Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC.
Hosui A, Hayata N, Kurahashi T, Namiki A, Okamoto A, Aochi K, Ashida M, Tanimoto T, Murai H, Ohnishi K, Hirao M, Yamada T, Hiramatsu N.
Hosui A, et al. Among authors: ohnishi k.
Cancers (Basel). 2025 Jan 8;17(2):185. doi: 10.3390/cancers17020185.
Cancers (Basel). 2025.
PMID: 39857967
Free PMC article.